Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (£272m) over five years because of the United States' request for sensitive biological samples.
This move came to light following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesperson has since explained that the United States was requesting genetic material for research and commercial gain while was not willing to guarantee the benefits from any future treatments.
"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can continue.
Broader Implications
This development comes after a similar case in neighbouring Kenya, where a high court halted a related deal with the US after legal challenges were raised about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost openness and responsibility.
As per reports, 16 nations in Africa have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any corresponding promise of access to any medical innovations – like new medicines or tests – that could result from that shared data," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our people if a new disease outbreak arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining systems previously set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how subsequent co-operation might be arranged in a manner that respects the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks should continue considering much of the nation's Aids initiatives were funded by foreign aid.
"Where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The situation highlights the complex debate between accepting much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.